Sarcopenia and Outcomes of Neuroplasty in Lumbar Spinal Stenosis

Sarcopenia Clinical Trial

Official title: The Influence of Sarcopenia on Outcomes of Neuroplasty in Patients With Lumbar Spinal Stenosis: a Prospective Observational Study

Status Active, not recruiting

Clinical Trial Summary

The aim of the present study is to find out the influence of sarcopenia on outcomes of neuroplasty in patients with lumbar spinal stenosis.

Clinical Trial Description

Frailty is an aging-related syndrome of physiological decline and correlated with sarcopenia. Furthermore, lumbar spinal stenosis is a common disease in the old population and a neuroplasty is widely used to treat these patients. We postulate that the sarcopenia may be associated with the outcome of neuroplasty in patients with lumbar spinal stenosis, and there is no study about this topic as far as we know.

To evaluate this association, we will use the criteria for sarcopenia which is made by Asian Working Group for Sarcopenia in 2019 in this study. We will compare the outcome of neuroplasty in patients with sarcopenia and without sarcopenia using several tools such as numeric rating scale (NRS), Oswestry Disability Index (ODI), and global perceived effect (GPE) score up to 6 months after the procedure. ;

Related Conditions & MeSH terms

• Constriction, Pathologic
• Intermittent Claudication
• Lumbar Spinal Stenosis
• Neurogenic Claudication
• Sarcopenia
• Spinal Stenosis

• NCT number: NCT04374669
• Study type: Observational [Patient Registry]
• Source: Asan Medical Center
• Status: Active, not recruiting
• Start date: May 20, 2020
• Completion date: April 30, 2023